South Korea granted conditional approval for Moderna’s Covid-19 vaccine on Friday, according to Food and Drug Safety Minister Kim Ganglip.
Two rounds of 0.5 ml of the Moderna vaccine can be administered to people age 18 or older, with a four-week interval between the first and second shot.
Moderna’s vaccine is the fourth Covid-19 vaccine to be approved in South Korea, after AstraZeneca, Pfizer and Johnson & Johnson.
Kim said the approval comes with the condition that the company submits a final report about clinical trials.
South Korea has fully vaccinated just 2.5% of its population, according to CNN's vaccine tracker.